Press release from Business Wire
Illumina to Announce Third Quarter 2013 Financial Results on Monday, October 21, 2013
Monday, October 07, 2013
Illumina to Announce Third Quarter 2013 Financial Results on Monday, October 21, 201306:35 EDT Monday, October 07, 2013
SAN DIEGO (Business Wire) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for third quarter 2013 following the close of market on Monday, October 21, 2013.
On the same day, at 2:00 pm Pacific Time (5:00 pm Eastern Time) Jay Flatley, President and Chief Executive Officer; Marc Stapley, Senior Vice President and Chief Financial Officer; and Christian Henry, Senior Vice President and General Manager, Genomic Solutions, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.
Conference Call Details
The conference call will begin at 2:00 pm Pacific Time (5:00 pm Eastern Time) on Monday, October 21, 2013. Interested parties may listen to the call by dialing 888-680-0869 (passcode: 91263308), or if outside North America, by dialing +1-617-213-4854 (passcode: 91263308). Individuals may access the live teleconference in the Investor Relations section of Illumina's web site under the “Company” tab at www.illumina.com.
A replay of the conference call will be available from 6:00 pm Pacific Time (9:00 pm Eastern Time) on October 21, 2013 through October 28, 2013 by dialing 888-286-8010 (passcode: 82917243), or if outside North America, by dialing +1-617-801-6888 (passcode: 82917243).
Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.
Rebecca Chambers, 858-255-5243
Jennifer Temple, 858-882-6822